Close

AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper Jaffray

Go back to AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper Jaffray

BTIG Trims PT on AtriCure (ATRC) to $19; Management 'Disconnect' Causes Concern

August 8, 2016 11:17 AM EDT

BTIG cut its price target on Buy-rated AtriCure (NASDAQ: ATRC) from $34 down to $19 after the company reported Q2 results late last week.

Analyst Sean Lavin commented, ATRC reported a relatively in-line but messy quarter with the core business coming in soft while increased focus on nContact... More

Needham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy

August 5, 2016 8:34 AM EDT

Needham & Company maintained a Buy rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $20.00 (from $23.00), following the company's 2Q earnings report. Revenue was reported at $39.7M, a slight beat to the consensus estimate of $39.8M. EPS was ($0.26), ahead of consensus of ($0.30). ATRC lowered its... More

AtriCure (ATRC) Tops Q2 EPS by 4c

August 4, 2016 5:16 PM EDT

AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $39.84 million.

"We are pleased to report second quarter results which reflect many accomplishments we launched two new... More